Collects blood and spinal fluid samples from people with various conditions for research
Collects blood and spinal fluid samples from adults with certain neurological conditions and cancers.
Key facts
- Who runs it
- Hospices Civils de Lyon
- Where
- Bron, FranceSee the site
- Trial code
- Registry title
- Control Cohort CTRL COH
- Status
- Recruiting
- People taking part
- 350 people, planned
- Started
- 8 Aug 2023
- Expected to end
- 8 Aug 2028
- Type of study
- Interventional
- Treatments tested
- Collection of biological sample (blood and/or CSF)
- Record updated
- 15 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who agree to take part and have Parkinson's disease, ALS, glioblastoma, a cancer without nerve disease, or rheumatoid arthritis. They act as a control group.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Parkinson's disease, amyotrophic lateral sclerosis, glioblastoma, cancer without neurological disease (lung, breast, ovarian cancer, melanoma, thymoma), or rheumatoid arthritis. No stage is given.
Main reasons for not taking part
- Refusing consent
- A nerve disorder that fits paraneoplastic neurological syndrome or autoimmune encephalitis
- Being under guardianship
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- patient with consent
- patient with following disease: Parkinson's disease, Amyotrophic lateral sclerosis, Glioblastoma, cancer without neurological disease (pulmonary cancer, breast cancer, ovarian cancer, melanoma, thymoma), rheumatoid arthritis
Who cannot take part
- patient with neurological disorder compatible with paraneoplastic neurological syndrome or auto-immune encephalitis
- refusal consent
- patient under guardianship
Where in France
- Hospices Civils de LyonBron, FranceContact: Jerome HONNORAT, PrTaking people
About the trial
What the trial wants to find out
Autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS) are rare disease that could be difficult to diagnose. So it necessary to obtain numerous sample from different disease to develop more specific diagnosis kit It could be possible through the characterisation of new genetic biomarkers.
The group in the trial
- Control cohortOther group
Patient with following disease: Parkinson's disease, Amyotrophic lateral sclerosis, Glioblastoma, cancer without neurological disease (pulmonary cancer, breast cancer, ovarian cancer, melanoma, thymoma), rheumatoid arthritis.
Treatment: Collection of biological sample (blood and/or CSF)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Control Cohort CTRL COH
- Plain-language title
- Collects blood and spinal fluid samples from people with various conditions for researchGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 15 January 2026